NAPSA

Protein-coding gene in humans From Wikipedia, the free encyclopedia

Napsin-A is an aspartic proteinase that is encoded in humans by the NAPSA gene.[5] The name napsin comes from novel aspartic proteinase of the pepsin family.[6]

AliasesNAPSA, KAP, Kdap, NAP1, NAPA, SNAPA, napsin A aspartic peptidase
End50,365,830 bp[1]
Quick facts Identifiers, Aliases ...
NAPSA
Identifiers
AliasesNAPSA, KAP, Kdap, NAP1, NAPA, SNAPA, napsin A aspartic peptidase
External IDsOMIM: 605631; MGI: 109365; HomoloGene: 68418; GeneCards: NAPSA; OMA:NAPSA - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004851

NM_008437

RefSeq (protein)

NP_004842

NP_032463

Location (UCSC)Chr 19: 50.36 – 50.37 MbChr 7: 44.22 – 44.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

The activation peptide of an aspartic proteinase acts as an inhibitor of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.[5]

Utility

Detection of NAPSA gene expression can be used to distinguish adenocarcinomas from other forms of lung cancer.[7]

References

Further reading

Related Articles

Wikiwand AI